Comment on OMB-2026-0034-0001

Summary: Voices of Alzheimer’s, a national patient advocacy organization, opposes the proposed rule because it would destabilize Alzheimer’s research by allowing for discretionary termination of awards, subordinating scientific peer review to political appointees, and imposing burdensome administrative restrictions. They argue these changes would undermine long-term research stability, exclude community-based nonprofits, and hinder the development of life-saving treatments.